New scanner aims to sharpen cancer radiation targeting
NCT ID NCT06576908
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new on-couch imaging system called HyperSight, which takes 3D X-ray pictures (CBCT) of cancer patients right before their radiation treatment. 46 adults with head/neck, chest, abdomen, or pelvic cancers received both the new HyperSight scan and a standard scan on their first, second, and last days of radiation. The goal was to compare image quality and see if the new system could provide clearer pictures to help doctors aim radiation more accurately.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HyperSight imaging device
What this could lead to
If successful, this imaging technology could help doctors see tumors more clearly during radiation treatment, potentially leading to more precise targeting and fewer side effects.
What could go wrong
This is a small, completed imaging study that only assessed image quality, not treatment outcomes. Better images may not always translate into better patient results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre (University Health Network)
Toronto, Ontario, M5G 2M9, Canada